An AI-powered pathology tool called PhenopyCell can accurately predict whether patients with small cell lung cancer will respond to platinum-based chemotherapy, according to a study published March 17 in npj Precision Oncology. Researchers evaluated the tool on standard pathology slides…
Oncology
This month, Alabama enacted HB300, a law that requires health plans to cover breast exams without a deductible, copay or coinsurance. Diagnostic breast exams include mammography, MRIs, ultrasounds and molecular imaging used for detecting and understanding abnormalities. Health plans must…
Menomonee Falls, Wis.-based Froedtert ThedaCare Health and Milwaukee-based Medical College of Wisconsin have opened Wisconsin’s first proton therapy facility. The facility is located at the Froedtert & the Medical College of Wisconsin Clinical Cancer Center on the Froedtert Hospital campus…
A molecular test designed by researchers at Pittsburgh-based UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine detected nearly twice as many bile duct cancers as standard pathology, according to a study published March 27 in Gastroenterology.…
Complex prompting may yield more successful results when using AI to analyze physician interviews with pediatric cancer survivors, according to a study published March 25 in Communications Medicine. For the study, researchers from Memphis, Tenn.-based St. Jude Children’s Research Hospital…
Advertisement
As clinical trial decentralization gains traction, there is one bottleneck limiting equitable access: inconsistent patient identification. Becker’s spoke to 14 oncology industry leaders about which strategies are most critical to expanding access — and where gaps remain. The contributors to…
Baltimore-based University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center will launch a cancer researcher training program through a $3 million National Cancer Institute grant. The Advancing Oncologic Research Communities in Health Equity program will support early-career faculty and…
Between 1990 and 2021, the global incidence of early-onset cancers grew while mortality fell, according to a study published Feb. 4 in JCO Global Oncology. Researchers from academic institutions around the world analyzed data from the 2021 Global Burden of…
Dallas-based UT Southwestern Medical Center has partnered with InterAct Therapeutics to develop and commercialize a gene therapy designed to treat breast cancer liver metastasis. The partnership builds on the research of Isaac Chan, MD, PhD, assistant professor of internal medicine…
Lebanon, N.H.-based Dartmouth Health and Hanover, N.H.-based Dartmouth Geisel School of Medicine have named Roy Herbst, MD, PhD, director of the Dartmouth Cancer Center. Dr. Herbst currently serves as deputy director and chief of medical oncology and hematology at Yale…